Reduction of the dendritic arbor length and the lack of dendritic spines in the pyramidal cells of the prefrontal cortex (PFC) are prevalent pathological features in schizophrenia (SZ). Neonatal ventral hippocampus lesion (NVHL) in male rats reproduces these neuronal characteristics and here we describe how this is a consequence of BDNF/TrkB pathway disruption. Moreover, COX-2 proinflammatory state, as well as Nrf-2 antioxidant impairment, triggers oxidative/nitrosative stress, which also contributes to dendritic spine impairments in the PFC. Interestingly, oxidative/nitrosative stress was also detected in the periphery of NVHL animals. Furthermore, risperidone treatment had a neurotrophic effect on the PFC and antioxidant effects on the brain and periphery of NVHL animals; these cellular effects were related to behavioral improvement. Our data highlight the link between brain development and immune response, as well as several other factors to understand mechanisms related to the pathophysiology of SZ.SIGNIFICANCE STATEMENTPrefrontal cortex dysfunction in schizophrenia can be a consequence of morphological abnormalities and oxidative/nitrosative stress, among others. Here, we detailed how impaired plasticity-related pathways and oxidative/nitrosative stress are part of the dendritic spine pathology and their modulation by atypical antipsychotic risperidone treatment in rats with neonatal ventral hippocampus lesion. Moreover, we found that animals with neonatal ventral hippocampus lesion had oxidative/nitrosative stress in the brain as well as in the peripheral blood, an important issue for the translational approaches of this model. Then, risperidone restored plasticity and reduced oxidative/nitrosative stress of prefrontal cortex pyramidal cells, and ultimately improved the behavior of lesioned animals. Moreover, risperidone had differential effects than the brain on peripheral blood oxidative/nitrosative stress.
Coronavirus disease 2019 (COVID-19) has impacted mental health worldwide, and suicide can be a serious outcome of this. Thus, suicide characteristics were examined before and during the COVID-19 pandemic in Mexico City. This is a retrospective study including all Mexico City residents who had a coroner's record with a cause of death of intentional self-harm (ICD-10) from January 2016 to December 2021. From 2016 to 2021, 3636 people committed suicide, of which 2869 were males (78.9%) and 767 females (21.1%). From 2016 to 2019 the suicide rate remained constant (∼6 per 100000) and dramatically increased in 2020 (10.45 per 100,000), to return to the levels of the previous year in 2021 (6.95 per 100000). The suicide rate in 2020 specifically increased from January to June (COVID-19 outbreak) in all age groups. Moreover, every year young people (15–24 years) have the maximum suicide rate and depression was the main suicide etiology. The COVID-19 pandemic outbreak increased the suicide rate, regardless of age, but suicide prevalence was higher in males and young people, regardless of the COVID-19 pandemic. These findings confirm that suicide is a complex and multifactorial problem and will allow the establishment of new guidelines for prevention and care strategies.
Suicide is a major public health concern frequently associated with depressive disorders and neurobiological alterations within the hippocampus. This study investigated biomarkers related to neuroinflammation, oxidative/nitrosative stress, and mitochondrial labeling in the CA1 region of the hippocampus of young and adult individuals of Mexican ancestry who died by suicide. Postmortem hippocampal CA1 samples were obtained from young and adult suicide cases and age-matched controls. Cellular markers of microglia (ionized calcium-binding adapter molecule 1, Iba1) and astrocytes (glial fibrillary acidic protein, GFAP), neuronal density, glucocorticoid receptor expression, and mitochondrial labeling were evaluated and compared among groups. Suicide cases exhibited increased microglial and astrocyte cell density indicated by increased Iba1 and GFAP immunoreactivity in both age groups. In contrast, mitochondrial labeling and glucocorticoid receptor immunoreactivity were reduced in suicide cases, regardless of age. Additionally, a significant reduction in neuronal density was detected exclusively in young individuals who died by suicide. Together, these findings indicate age-independent alterations in glial immunoreactivity, mitochondrial labeling, and glucocorticoid receptor expression, alongside reduced neuronal density in the hippocampal CA1 region of younger suicide cases, supporting the involvement of neuroinflammation-related processes in suicide. Despite the limited sample size, these findings provide insight into potential neurobiological mechanisms underlying suicide and may contribute to the identification of biomarkers and therapeutic targets for individuals at risk.